BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28628422)

  • 1. T1ρ-weighted Dynamic Glucose-enhanced MR Imaging in the Human Brain.
    Paech D; Schuenke P; Koehler C; Windschuh J; Mundiyanapurath S; Bickelhaupt S; Bonekamp D; Bäumer P; Bachert P; Ladd ME; Bendszus M; Wick W; Unterberg A; Schlemmer HP; Zaiss M; Radbruch A
    Radiology; 2017 Dec; 285(3):914-922. PubMed ID: 28628422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast and Quantitative T1ρ-weighted Dynamic Glucose Enhanced MRI.
    Schuenke P; Paech D; Koehler C; Windschuh J; Bachert P; Ladd ME; Schlemmer HP; Radbruch A; Zaiss M
    Sci Rep; 2017 Feb; 7():42093. PubMed ID: 28169369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiabatically prepared spin-lock approach for T1ρ-based dynamic glucose enhanced MRI at ultrahigh fields.
    Schuenke P; Koehler C; Korzowski A; Windschuh J; Bachert P; Ladd ME; Mundiyanapurath S; Paech D; Bickelhaupt S; Bonekamp D; Schlemmer HP; Radbruch A; Zaiss M
    Magn Reson Med; 2017 Jul; 78(1):215-225. PubMed ID: 27521026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T1ρ-based dynamic glucose-enhanced (DGEρ) MRI at 3 T: method development and early clinical experience in the human brain.
    Herz K; Lindig T; Deshmane A; Schittenhelm J; Skardelly M; Bender B; Ernemann U; Scheffler K; Zaiss M
    Magn Reson Med; 2019 Nov; 82(5):1832-1847. PubMed ID: 31231853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic glucose enhanced (DGE) MRI for combined imaging of blood-brain barrier break down and increased blood volume in brain cancer.
    Xu X; Chan KW; Knutsson L; Artemov D; Xu J; Liu G; Kato Y; Lal B; Laterra J; McMahon MT; van Zijl PC
    Magn Reson Med; 2015 Dec; 74(6):1556-63. PubMed ID: 26404120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced MR Imaging versus Contrast-enhanced US: A Comparison in Glioblastoma Surgery by Using Intraoperative Fusion Imaging.
    Prada F; Vitale V; Del Bene M; Boffano C; Sconfienza LM; Pinzi V; Mauri G; Solbiati L; Sakas G; Kolev V; D'Incerti L; DiMeco F
    Radiology; 2017 Oct; 285(1):242-249. PubMed ID: 28562204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.
    Heo YJ; Kim HS; Park JE; Choi CG; Kim SJ
    PLoS One; 2015; 10(8):e0136380. PubMed ID: 26296086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
    Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
    Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging.
    Kickingereder P; Wiestler B; Sahm F; Heiland S; Roethke M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
    Radiology; 2014 Sep; 272(3):843-50. PubMed ID: 24814181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Dynamic Oxygen 17 MRI at 7.0 T for the Cerebral Oxygen Metabolism in Glioma.
    Paech D; Nagel AM; Schultheiss MN; Umathum R; Regnery S; Scherer M; Wick A; Platt T; Wick W; Bendszus M; Unterberg A; Schlemmer HP; Ladd ME; Niesporek SC
    Radiology; 2020 Apr; 295(1):181-189. PubMed ID: 32068505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.
    Kim HS; Goh MJ; Kim N; Choi CG; Kim SJ; Kim JH
    Radiology; 2014 Dec; 273(3):831-43. PubMed ID: 24885857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subarachnoid hemorrhage in the subacute stage: elevated apparent diffusion coefficient in normal-appearing brain tissue after treatment.
    Liu Y; Soppi V; Mustonen T; Könönen M; Koivisto T; Koskela A; Rinne J; Vanninen RL
    Radiology; 2007 Feb; 242(2):518-25. PubMed ID: 17179395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved postprocessing of dynamic glucose-enhanced CEST MRI for imaging brain metastases at 3 T.
    Wu Y; Derks SHAE; Wood TC; de Blois E; van der Veldt AAM; Smits M; Warnert EAH
    Eur Radiol Exp; 2023 Dec; 7(1):78. PubMed ID: 38066225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of Dynamic Contrast-enhanced and Diffusion-weighted MR Imaging in the Detection of Pathologic Complete Response in Cervical Cancer after Neoadjuvant Therapy: A Retrospective Observational Study.
    Jalaguier-Coudray A; Villard-Mahjoub R; Delouche A; Delarbre B; Lambaudie E; Houvenaeghel G; Minsat M; Tallet A; Sabatier R; Thomassin-Naggara I
    Radiology; 2017 Aug; 284(2):432-442. PubMed ID: 28301309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted MR of the brain: methodology and clinical application.
    Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
    Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
    Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
    Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Axonal Disease in Patients with Multiple Sclerosis Using High-Gradient-Diffusion MR Imaging.
    Huang SY; Tobyne SM; Nummenmaa A; Witzel T; Wald LL; McNab JA; Klawiter EC
    Radiology; 2016 Jul; 280(1):244-51. PubMed ID: 26859256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging of glioblastoma in children: usefulness of diffusion/perfusion-weighted MRI and MR spectroscopy.
    Chang YW; Yoon HK; Shin HJ; Roh HG; Cho JM
    Pediatr Radiol; 2003 Dec; 33(12):836-42. PubMed ID: 14564423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High b-value diffusion-weighted MR imaging of normal brain at 3T.
    Cihangiroglu M; Uluğ AM; Firat Z; Bayram A; Kovanlikaya A; Kovanlikaya I
    Eur J Radiol; 2009 Mar; 69(3):454-8. PubMed ID: 18162352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.